This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Celgene Corporation. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations in Cancer Treatment by Jorge Dimartino
Introduction
Jorge Dimartino is a notable inventor based in Belmont, NJ (US), recognized for his contributions to the field of cancer treatment. He holds a patent that focuses on innovative methods for treating locally advanced breast cancer, including inflammatory breast cancer. His work aims to improve patient outcomes through advanced therapeutic strategies.
Latest Patents
Dimartino's patent, titled "Methods for the treatment of locally advanced breast cancer," outlines methods for treating, preventing, and managing this challenging condition. The patent details the administration of one or more immunomodulatory compounds or their enantiomers, as well as various pharmaceutical forms such as salts, solvates, hydrates, co-crystals, clathrates, or polymorphs. This innovative approach represents a significant advancement in the treatment of breast cancer.
Career Highlights
Throughout his career, Jorge Dimartino has worked with prominent companies in the pharmaceutical industry, including Celgene Corporation and Astex Pharmaceuticals, Inc. His experience in these organizations has contributed to his expertise in developing effective cancer therapies.
Collaborations
Dimartino has collaborated with esteemed colleagues such as Anita Gandhi and Rajesh Chopra, further enhancing his research and development efforts in the field of oncology.
Conclusion
Jorge Dimartino's innovative work in cancer treatment exemplifies the impact of dedicated inventors in the medical field. His patent for methods of treating locally advanced breast cancer showcases his commitment to improving patient care and advancing therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
